Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,000 people and operates in more than 150 countries worldwide. Its 2004 sales were in excess of $1.8 billion. Merial Limited is a joint venture between Merck & Co. and sanofi-aventis.  

• Merial is committed to enhancing the health, well-being and performance of animals. Our strengths in parasite control and disease prevention are known around the world.
• Many Merial products are considered gold standards in their categories. For example, FRONTLINE® brand products have achieved success as the undisputed leader in flea & tick control.
• IVOMEC® entered pharmaceutical history as the single most successful animal health product ever launched. This family of products enjoys high brand equity and has been used for more than two decades among cattle ranchers, beef and dairy producers, and veterinarians.
• Merial’s customer-driven focus led to a re-organization along global enterprises to help deliver greater value to customers. The global enterprises focus on products for production animals (such as cattle, swine, and chickens) and companion animals (such as dogs, cats and horses).
• Merial is a supporter of the veterinarian community and the agricultural industry.
• Merial's makes significant investments in R&D, and the company has launched one new product every year globally since the company’s inception.